| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |